biote Corp.
BTMDW
Other OTC1.61
USD
+0.25
- -
CIK
0001819253
CUSIP
090683111
Return %
Stock
S&P500
1Y
490.39
26.84
3Y
151.56
77.03
5Y
151.56
80.55
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Marc D. Beer
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- Address
- 1875 West Walnut Hill Lane Irving TX United States of America 75038
- IPO Date
- May 27, 2022
- CIK
- 0001819253
- Website
- biote.com
- Similar Companies
- Business
- biote Corp. operates a comprehensive medical practice-building enterprise within the growing hormone optimization and therapeutic wellness sector. The company provides a specialized platform, known as the Biote Method, to empower certified healthcare practitioners with the essential components for establishing and growing hormone optimization centers. This encompasses in-depth education, training, sophisticated practice management software, and advanced clinical decision support tools for precise, personalized patient care. Practitioners leverage this system to address hormone, vitamin, and mineral imbalances in their patients, primarily through bioidentical hormone replacement pellet therapy for both men and women, alongside suggesting a selection of Biote-branded dietary supplements. The company also supplies necessary sterile pellet insertion kits. This approach is designed to assist a wide range of individuals experiencing hormonal deficiencies, fostering improved well-being and healthier aging. Established in 2012, biote Corp. maintains its headquarters in Irving, Texas.